Compounded tirzepatide
Sold by Lovely Meds · Injection, vial · every compounded tirzepatide record
What you actually pay
Per month
$235
| Medication · Month to month | $235 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Month to month “1 Month $235/mo” source, read September 2, 2026 | Per month$235 | Charged today$235 |
| 3 month plan “3 Months $199/mo” source, read September 2, 2026 | Per month$199 | Charged today$199 |
| 6 month plan “6 Months $175/mo” source, read September 2, 2026 | Per month$175 | Charged today$175 |
| 12 month plan (Best Value) “12 Months Best Value $150/mo” source, read September 2, 2026 | Per month$150 | Charged today$150 |
We earn nothing from this link. Lovely Meds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- September 2, 2026 — $235
- September 3, 2026 — $235
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | The Pharmacy Hub; Hallandale Pharmacy; Vials RX; Greenwich RX; Strive Pharmacy; Partell Specialty Pharmacy; HealthWarehouse.com |
|---|---|
| States | Not disclosed |
| Cancellation | “a. Cancellation Before Prescriber Review If you cancel your order before a provider review begins, a $40 administrative fee will apply.” |
Not yet checked: prescriber, membership and consult fee.
Recorded from lovelymeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Homepage advertises 'Compounded GLP-1 plans from $99/mo' and product pages show a first-month promo price ($39 for semaglutide, $90 for tirzepatide with code NEW60) on top of the 12-month-plan $99/$150 rate — those promo figures are discounts off the listed plan prices, not separate standing prices, so they were left out of `prices`. Brand pages (Wegovy, Zepbound, Ozempic) list no dollar figure, only 'Prices vary depending on the strength and length of treatment.' The oral-semaglutide page never states which physical form (tablet/drop/troche) the $209/mo price applies to, despite the nav listing Semaglutide Drop, Troche, and ODT as separate SKUs — recorded as not-disclosed rather than guessed. No sync/async prescriber detail was stated in the pages checked.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.